Acute procedural safety of the latest radiofrequency ablation catheters in atrial fibrillation ablation: Data from a large prospective ablation registry

• Published in: Journal of cardiovascular electrophysiology Vol. 35; no. 11; pp. 2109 - 2118
• Main Authors: Arai, Hirofumi, Miyazaki, Shinsuke, Nitta, Junichi, Inamura, Yukihiro, Shirai, Yasuhiro, Tanaka, Yasuaki, Nagata, Yasutoshi, Sekiguchi, Yukio, Inaba, Osamu, Sagawa, Yuichiro, Mizukami, Akira, Azegami, Koji, Iwai, Shinsuke, Hachiya, Hitoshi, Ono, Yuichi, Sasaki, Takeshi, Takahashi, Atsushi, Yamauchi, Yasuteru, Okada, Hiroyuki, Suzuki, Atsushi, Suzuki, Makoto, Handa, Keita, Hirao, Kenzo, Nishimura, Takuro, Tao, Susumu, Takigawa, Masateru, Sasano, Tetsuo
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.11.2024
• Subjects: Ablation; atrial fibrillation; Cardiac arrhythmia; cardiac tamponade; Catheters; Clinical medicine; Fibrillation; Heart; Multivariate analysis; radiofrequency catheter ablation; Tamponade; radiofrequency catheter ablation; atrial fibrillation; cardiac tamponade
• ISSN: 1045-3873; 1540-8167; 1540-8167
• DOI: 10.1111/jce.16408

Background Safety data of the latest radiofrequency (RF) technologies during atrial fibrillation (AF) ablation in real‐world clinical practice are limited. Objectives We sought to evaluate the acute procedural safety of the four latest ablation catheters commonly used for AF ablation. Methods A total of 3957 AF ablation procedures performed between January 2022 and December 2023 at 20 centers with either the THERMOCOOL SMARTTOUCH SF (STSF), TactiCath (TC), QDOT Micro (QDM), or TactiFlex (TF) were retrospectively analyzed. Results In total, QDM, STSF, TF, and TC were used in 343 (8.7%), 1793 (45.3%), 1121 (28.4%), and 700(17.7%) procedures. Among 2406 index procedures, electrical pulmonary vein isolations were successfully achieved in 99.5%. Despite similar total procedure times in the four groups, the total fluoroscopic time was significantly shorter for QDM/STSF with CARTO than TF/TC with EnSite (18.7 ± 14 vs. 27.6 ± 20.6 min, p < .001) and longest in the TF group. The incidence of cardiac tamponade was 0.7% (0.5% and 0.9% during index and redo procedures, 0.8% and 0.3% for paroxysmal and non‐paroxysmal AF) and was significantly lower for QDM/STSF than TF/TC (0.2% vs. 1.1%, p = .008) and highest in the TF group. The incidence of cardiac tamponade was higher for TF than TC and STSF than QDM. In the multivariate analysis, TF/TC with EnSite was a significant independent predictor of cardiac tamponade during both the index (odds ratio [OR] = 4.8, 95% confidence interval [CI] = 1.3–17.5, p = .02) and all procedures (OR = 3.0, 95% CI = 1.3–7.2, p = .01). Conclusions The incidence of cardiac tamponade and the fluoroscopic time during AF ablation significantly differed among the latest RF catheters and mapping systems in real‐world clinical practice.